Filing Flows › Scientist Home Future Health (SHFH) › Q3 2025
Scientist Home Future Health (SHFH) Q3 2025 earnings results (third quarter 2025)
10-Q filed Nov 12, 2025
Scientist Home Future Health (SHFH) reported revenue of $40K for the third quarter 2025 (Q3 2025), -33% from a year earlier and +26% from the quarter before. Operating margin was -120.8%, net loss $48K (120.8% of revenue).
Scientist Home Future Health, Q3 2025: revenue $40K (-33% year over year), operating margin -120.8%, net loss $48K, operating cash flow −$99K. The chart follows the revenue to costs, profit and cash.
| Q3 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $40K | +26% | -33% |
| Operating profit | −$48K | — | — |
| Net earnings | −$48K | — | — |
| Operating cash flow | −$99K | — | — |
What changed
Revenue was $40K in Q3 2025, down 33% year over year and up 26% from the previous quarter. Scientist Home Mixed Gelatine Hydrolysate was the largest line at 45% of revenue.
Gross margin was 40.6%, down 3.9 points from a year earlier. Operating costs exceeded revenue by $48K, an operating margin of -120.8%. Operating expenses grew 161% against a revenue fall of 33%. The quarter ended with a net loss of $48K, wider than the previous quarter's $37K loss.
Operating cash flow was −$99K. Working capital and other items used $52K.
Questions
What was Scientist Home Future Health's revenue in the third quarter 2025?
Scientist Home Future Health (SHFH) reported revenue of $40K for the third quarter 2025 (Q3 2025), -33% from a year earlier and +26% from the quarter before.
Was Scientist Home Future Health profitable in the third quarter 2025?
Operating loss was $48K (-120.8% of revenue) and net loss $48K.